SE461190B - Foerfarande foer foervaring av blod samt behaallare innehaallande antihemolytiskt medel - Google Patents
Foerfarande foer foervaring av blod samt behaallare innehaallande antihemolytiskt medelInfo
- Publication number
- SE461190B SE461190B SE8000926A SE8000926A SE461190B SE 461190 B SE461190 B SE 461190B SE 8000926 A SE8000926 A SE 8000926A SE 8000926 A SE8000926 A SE 8000926A SE 461190 B SE461190 B SE 461190B
- Authority
- SE
- Sweden
- Prior art keywords
- blood
- agent
- container
- ester
- process according
- Prior art date
Links
- 210000004369 blood Anatomy 0.000 title claims description 91
- 239000008280 blood Substances 0.000 title claims description 91
- 230000002587 anti-hemolytic effect Effects 0.000 title claims description 45
- 238000000034 method Methods 0.000 title claims description 30
- 239000000463 material Substances 0.000 claims description 74
- 239000003795 chemical substances by application Substances 0.000 claims description 43
- 239000000839 emulsion Substances 0.000 claims description 33
- 229920003023 plastic Polymers 0.000 claims description 31
- 239000004033 plastic Substances 0.000 claims description 31
- 150000002148 esters Chemical class 0.000 claims description 25
- 239000004014 plasticizer Substances 0.000 claims description 17
- 238000003860 storage Methods 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical group CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 11
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 claims description 10
- -1 phosphate ester Chemical class 0.000 claims description 9
- 239000003219 hemolytic agent Substances 0.000 claims description 7
- 206010018910 Haemolysis Diseases 0.000 claims description 6
- 230000008588 hemolysis Effects 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- HBGGXOJOCNVPFY-UHFFFAOYSA-N diisononyl phthalate Chemical group CC(C)CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCC(C)C HBGGXOJOCNVPFY-UHFFFAOYSA-N 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 4
- 239000004800 polyvinyl chloride Substances 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 claims description 2
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 claims description 2
- ZVFDTKUVRCTHQE-UHFFFAOYSA-N Diisodecyl phthalate Chemical group CC(C)CCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C ZVFDTKUVRCTHQE-UHFFFAOYSA-N 0.000 claims description 2
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 claims description 2
- 125000004437 phosphorous atom Chemical group 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 11
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 230000001804 emulsifying effect Effects 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 description 11
- 108010054147 Hemoglobins Proteins 0.000 description 11
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 11
- 229920000053 polysorbate 80 Polymers 0.000 description 11
- 239000013068 control sample Substances 0.000 description 8
- 150000002430 hydrocarbons Chemical group 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- KRADHMIOFJQKEZ-UHFFFAOYSA-N Tri-2-ethylhexyl trimellitate Chemical compound CCCCC(CC)COC(=O)C1=CC=C(C(=O)OCC(CC)CCCC)C(C(=O)OCC(CC)CCCC)=C1 KRADHMIOFJQKEZ-UHFFFAOYSA-N 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 239000004743 Polypropylene Substances 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- KCXZNSGUUQJJTR-UHFFFAOYSA-N Di-n-hexyl phthalate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC KCXZNSGUUQJJTR-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 239000011324 bead Substances 0.000 description 2
- ROPXFXOUUANXRR-YPKPFQOOSA-N bis(2-ethylhexyl) (z)-but-2-enedioate Chemical compound CCCCC(CC)COC(=O)\C=C/C(=O)OCC(CC)CCCC ROPXFXOUUANXRR-YPKPFQOOSA-N 0.000 description 2
- WXZOXVVKILCOPG-UHFFFAOYSA-N bis(2-ethylhexyl) benzene-1,3-dicarboxylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC(C(=O)OCC(CC)CCCC)=C1 WXZOXVVKILCOPG-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- OEIWPNWSDYFMIL-UHFFFAOYSA-N dioctyl benzene-1,4-dicarboxylate Chemical compound CCCCCCCCOC(=O)C1=CC=C(C(=O)OCCCCCCCC)C=C1 OEIWPNWSDYFMIL-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PUFGCEQWYLJYNJ-UHFFFAOYSA-N didodecyl benzene-1,2-dicarboxylate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCCCCCC PUFGCEQWYLJYNJ-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000005187 nonenyl group Chemical group C(=CCCCCCCC)* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/0005—Use of materials characterised by their function or physical properties
- A61L33/0052—Plasticizers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/12—Esters; Ether-esters of cyclic polycarboxylic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- External Artificial Organs (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/105,468 US4326025A (en) | 1979-12-19 | 1979-12-19 | Anti-hemolytic agent emulsions and the use thereof |
| US06/105,469 US4451259A (en) | 1978-10-26 | 1979-12-19 | Blood storage method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8000926L SE8000926L (sv) | 1981-06-20 |
| SE461190B true SE461190B (sv) | 1990-01-22 |
Family
ID=26802613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8000926A SE461190B (sv) | 1979-12-19 | 1980-02-05 | Foerfarande foer foervaring av blod samt behaallare innehaallande antihemolytiskt medel |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4451259A (de) |
| AU (1) | AU5675280A (de) |
| BR (1) | BR8000978A (de) |
| CA (1) | CA1131562A (de) |
| DE (1) | DE3004522A1 (de) |
| DK (1) | DK47380A (de) |
| ES (1) | ES8103973A1 (de) |
| FR (1) | FR2471928B1 (de) |
| GB (1) | GB2065446B (de) |
| IL (1) | IL59274A0 (de) |
| IT (1) | IT1129697B (de) |
| NO (1) | NO800294L (de) |
| SE (1) | SE461190B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3169081D1 (en) * | 1980-10-31 | 1985-03-28 | Baxter Travenol Lab | Blood storage container and material |
| US5382526A (en) * | 1980-10-31 | 1995-01-17 | Baxter International Inc. | Blood storage container and material |
| JPS6133661A (ja) * | 1984-02-02 | 1986-02-17 | テルモ株式会社 | 医療用器具 |
| US5167657A (en) * | 1988-11-14 | 1992-12-01 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5100401A (en) * | 1988-11-14 | 1992-03-31 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US5026347A (en) * | 1988-11-14 | 1991-06-25 | Baxter International Inc. | Plastic composition with anti-hemolytic effect |
| US4943287A (en) * | 1989-07-17 | 1990-07-24 | Miles Inc. | Red blood cell storage system |
| FR2663220B1 (fr) * | 1990-06-15 | 2000-05-05 | Ensemble de poche-reservoir pour derivation veineuse. | |
| US5576368A (en) * | 1991-05-24 | 1996-11-19 | Toyoda Gosei Co., Ltd. | Steering wheel pad molded of a soft vinyl chloride resin composition |
| DE4217104A1 (de) * | 1992-05-22 | 1993-11-25 | Salama Magdy | Reservoir, Reservoir-System zur Inaktivierung, Hemmung und Eliminierung von Infektionserregern |
| AU4286996A (en) * | 1994-11-14 | 1996-06-06 | Pall Corporation | Long-term blood component storage system and method |
| US6113575A (en) * | 1998-05-14 | 2000-09-05 | Terumo Cardiovascular Systems Corporation | Volume control apparatus for a flexible venous reservoir |
| US9144958B2 (en) * | 2009-10-28 | 2015-09-29 | Fenwal, Inc. | Sheets for use with medical containers |
| US10398625B2 (en) | 2013-03-13 | 2019-09-03 | Fenwal, Inc. | Medical containers with terephthalate plasticizer for storing red blood cell products |
| KR102554521B1 (ko) | 2014-02-20 | 2023-07-11 | 프레제니우스 카비 도이치란트 게엠베하 | 적혈구 제품, 혈장 및 혈소판의 보관을 위한 비-ｄｅｈｐ 가소제를 갖는 의료용 컨테이너 및 시스템 구성요소 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2980964A (en) * | 1956-01-14 | 1961-04-25 | Distillers Co Yeast Ltd | Linear polyethylene films of improved transparency and method of making same |
| US3308086A (en) * | 1963-08-30 | 1967-03-07 | Union Carbide Corp | Ethylene copolymers with vinyl esters plasticized with phosphate and carboxylic esters |
| US3645955A (en) * | 1970-03-18 | 1972-02-29 | Scient Tube Products Inc | Plasticized radiopaque vinyl resin compositions |
| US4085082A (en) * | 1970-10-27 | 1978-04-18 | Ciba-Geigy Ag | Polymers of vinyl acetate plasticized with low molecular weight polyesters |
| US3749134A (en) * | 1972-02-02 | 1973-07-31 | Sunlite Plastics Inc | Radiographically opaque plastic tubing |
| US3940802A (en) * | 1975-01-24 | 1976-03-02 | The Green Cross Corporation | Medical appliance made of plastic |
| FR2324664A1 (fr) * | 1975-09-22 | 1977-04-15 | Rhone Poulenc Ind | Polyurethanes pour objets a usage medical |
| US4045431A (en) * | 1975-12-11 | 1977-08-30 | Eastman Kodak Company | Flexible polyester having a melting point of at least 140° C. |
| US4140162A (en) * | 1977-07-28 | 1979-02-20 | Baxter Travenol Lab | Clear, autoclavable plastic formulation free of liquid plasticizers |
| US4222379A (en) * | 1978-10-26 | 1980-09-16 | Baxter Travenol Laboratories, Inc. | Multiple blood bag having plasticizer-free portions and a high blood component survival rate |
| JPS5560459A (en) * | 1978-10-26 | 1980-05-07 | Baxter Travenol Lab | Polymer that can coexist with blood and medical appliance manufactured from said polymer |
| GB2035093B (en) * | 1978-10-26 | 1983-01-12 | Baxter Travenol Lab | Medical articles made of blood compatible polymers |
-
1979
- 1979-12-19 US US06/105,469 patent/US4451259A/en not_active Expired - Lifetime
-
1980
- 1980-01-30 IL IL59274A patent/IL59274A0/xx unknown
- 1980-01-31 IT IT19600/80A patent/IT1129697B/it active
- 1980-02-04 DK DK47380A patent/DK47380A/da not_active Application Discontinuation
- 1980-02-05 SE SE8000926A patent/SE461190B/sv not_active IP Right Cessation
- 1980-02-05 NO NO800294A patent/NO800294L/no unknown
- 1980-02-06 CA CA345,162A patent/CA1131562A/en not_active Expired
- 1980-02-07 DE DE19803004522 patent/DE3004522A1/de not_active Withdrawn
- 1980-02-15 BR BR8000978A patent/BR8000978A/pt unknown
- 1980-02-29 GB GB8006959A patent/GB2065446B/en not_active Expired
- 1980-03-21 FR FR8006333A patent/FR2471928B1/fr not_active Expired
- 1980-03-24 ES ES489862A patent/ES8103973A1/es not_active Expired
- 1980-03-24 AU AU56752/80A patent/AU5675280A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK47380A (da) | 1981-06-20 |
| GB2065446A (en) | 1981-07-01 |
| CA1131562A (en) | 1982-09-14 |
| IT1129697B (it) | 1986-06-11 |
| US4451259A (en) | 1984-05-29 |
| DE3004522A1 (de) | 1981-07-02 |
| SE8000926L (sv) | 1981-06-20 |
| ES489862A0 (es) | 1981-03-16 |
| IL59274A0 (en) | 1980-05-30 |
| ES8103973A1 (es) | 1981-03-16 |
| GB2065446B (en) | 1984-03-21 |
| NO800294L (no) | 1981-06-22 |
| BR8000978A (pt) | 1981-08-18 |
| IT8019600A0 (it) | 1980-01-31 |
| FR2471928A1 (fr) | 1981-06-26 |
| AU5675280A (en) | 1981-06-25 |
| FR2471928B1 (fr) | 1986-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4286597A (en) | Blood compatible polymers and medical devices made therefrom containing dioctyladipate plasticizer | |
| US4222379A (en) | Multiple blood bag having plasticizer-free portions and a high blood component survival rate | |
| SE461190B (sv) | Foerfarande foer foervaring av blod samt behaallare innehaallande antihemolytiskt medel | |
| US4670013A (en) | Container for blood and blood components | |
| EP0120873B1 (de) | Behälter einer blutkomponente und verfahren zur verwendung von weichgemachtem polyvinylchlorid frei oder wesentlich frei von auswaschbaren materialien | |
| US4301800A (en) | Blood bags having an insert member | |
| JPH0131904B2 (de) | ||
| AU646348B2 (en) | Plastic container with anti-hemolytic effect | |
| US5382526A (en) | Blood storage container and material | |
| EP0537863B1 (de) | Verwendung einer Triglyceridverbindung als Hämolysishemmer | |
| O'leary et al. | Toxicological studies on certain medical grade plastics sterilized by ethylene oxide | |
| US4507387A (en) | Method of storing red blood cells which minimizes both red blood cell hemolysis and exposure to blood extractable plasticizers | |
| AU623071B2 (en) | Hemolysis inhibitor and medical resin composition, medical implement, and blood-preserving fluid containing the same | |
| CA1227432A (en) | Method and container for storing platelets | |
| EP0114372A2 (de) | Aufbewahrungsbeutel für Blut und Blutbestandteile | |
| JP3014769B2 (ja) | 血小板保存容器 | |
| CA1251108A (en) | Multiple blood bag having plasticizer-free portions and a high blood component survival rate | |
| CA1231280A (en) | Multiple blood bag system | |
| CA1154684A (en) | Hemocompatible addition solutions and use thereof | |
| AU713648B2 (en) | Blood component preservation container and multi-linkage container system | |
| AU1947083A (en) | Method and container for storing platelets | |
| CA1306698C (en) | Hemolysis depressant, and medical resin composition, medical implement and blood preserving liquid using the hemolysis depressant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8000926-9 Effective date: 19920904 Format of ref document f/p: F |